The timeline and milestones of the basic studies for immune checkpoints, CTLA-4 and PD-1, are represented in Fig
The timeline and milestones of the basic studies for immune checkpoints, CTLA-4 and PD-1, are represented in Fig. therapy and novel ICIs currently under investigation in NSCLC. Although ICIs are now important pivotal malignancy therapy option in clinical settings, they show inconsistent therapeutic efficacy and limited responsiveness. Thus, newly proposed action mechanism to overcome the […]